Immunic, Inc.

IMUX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$35,668$46,674$106,745$86,863
Short-Term Investments$0$0$9,629$0
Receivables$684$703$296$2,150
Inventory$0$0$5,608$0
Other Curr. Assets$2,980$5,157$3,586$15,975
Total Curr. Assets$39,332$52,534$125,864$104,988
Property Plant & Equip (Net)$1,536$1,765$1,846$1,100
Goodwill$0$0$0$32,970
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$43$42
Total NC Assets$1,536$1,765$1,889$34,112
Other Assets$0$0$0$0
Total Assets$40,868$54,299$127,753$139,100
Liabilities
Payables$7,846$5,099$4,281$3,499
Short-Term Debt$740$695$571$408
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,589$18,935$8,225$7,494
Total Curr. Liab.$22,175$24,729$13,077$11,401
LT Debt$264$639$992$584
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$264$639$992$584
Other Liabilities$0$0$0$0
Cap. Leases$1,004$1,334$1,563$992
Total Liabilities$22,439$25,368$14,069$11,985
Equity
Pref Stock$0$0$0$0
Common Stock$8$4$4$3
Retained Earnings-$511,399-$410,892-$317,280-$196,873
AOCI$4,209$3,759$3,035-$252
Other Equity$525,611$436,060$427,925$324,237
Total Equity$18,429$28,931$113,684$127,115
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$40,868$54,299$127,753$139,100
Net Debt-$34,664-$45,340-$105,182-$85,871